Sulconazole
Generic name
Sulconazole
Brand name
ATC Code
D01AC09
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
After application to normal skin, the systemic absorption of sulconazole nitrate is about 10%.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Fungal infections of the skin |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIFUNGALS FOR TOPICAL USE
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antibiotics | ||
|---|---|---|
| D01AA01 | ||
| Imidazole and triazole derivatives | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC20 | ||
| Other antifungals for topical use | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
| IMIDAZOLE AND TRIAZOLE DERIVATIVES | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC20 | ||
| OTHER ANTIFUNGALS FOR TOPICAL USE | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
Reference
- Will Pharma BV, SmPC Myk (RVG 10875) 31-10-2005, www.cbg-meb.nl
Changes
Therapeutic Drug Monitoring
Overdose
